Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.01 USD | -6.81% | -8.09% | -6.52% |
May. 14 | Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $148,000 | MT |
May. 14 | Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.52% | 229M | |
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B |
- Stock Market
- Equities
- OVID Stock
- News Ovid Therapeutics Inc.
- Oppenheimer Initiates Coverage on Ovid Therapeutics With Outperform Rating, $8 Price Target